Takeda Pens Mid-Trial Settlement To Dismiss US Colcrys Antitrust Suit

Trio Of Generics Manufacturers Named In 2021 Suit Which Alleges Conspiracy Over Colchicine

 
• By Dean Rudge
  
Takeda HQ
Takeda has agreed to settle competition claims over Colcrys (colchicine)

More from Legal & IP

More from Generics Bulletin